Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (11-20 of 740) with videos related to

Pageof 74
Sort By:
Current Treatment Options in Oncology|July 20, 2007
Treatment of Waldenstrom's MacroglobulinemiaMeletios A Dimopoulos, Athanasios Anagnostopoulos
Hematology/Oncology Clinics of North America|September 8, 2018
Proteasome Inhibitors in Waldenström MacroglobulinemiaEfstathios Kastritis, Meletios A Dimopoulos
British Journal of Haematology|October 23, 2015
Recent advances in the management of AL AmyloidosisEfstathios Kastritis, Meletios A Dimopoulos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to D.L. CooperMeletios A Dimopoulos, Evangelos Terpos
Expert Opinion on Investigational Drugs|February 16, 2005
Thalidomide and immunomodulatory drugs in the treatment of cancerAristotle Bamias, Meletios A Dimopoulos
Leukemia & Lymphoma|November 17, 2006
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?Meletios A Dimopoulos, Efstathios Kastritis
Blood|August 23, 2014
Solitary bone plasmacytomas need to flowMeletios A Dimopoulos, Evangelos Terpos
Current Treatment Options in Oncology|June 12, 2002
Solitary bone plasmacytoma and extramedullary plasmacytomaMeletios A Dimopoulos, George Hamilos
Best Practice & Research. Clinical Haematology|November 10, 2016
Current therapy guidelines for Waldenstrom's macroglobulinaemiaEfstathios Kastritis, Meletios A Dimopoulos
Blood|February 1, 2014
Less strength and more fractures for MGUS bonesEvangelos Terpos, Meletios A Dimopoulos
Pageof 74

Showing results (11-20 of 740) with videos related to

Sort By:
Pageof 74
Current Treatment Options in Oncology|July 20, 2007
Treatment of Waldenstrom's MacroglobulinemiaMeletios A Dimopoulos, Athanasios Anagnostopoulos
Hematology/Oncology Clinics of North America|September 8, 2018
Proteasome Inhibitors in Waldenström MacroglobulinemiaEfstathios Kastritis, Meletios A Dimopoulos
British Journal of Haematology|October 23, 2015
Recent advances in the management of AL AmyloidosisEfstathios Kastritis, Meletios A Dimopoulos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to D.L. CooperMeletios A Dimopoulos, Evangelos Terpos
Expert Opinion on Investigational Drugs|February 16, 2005
Thalidomide and immunomodulatory drugs in the treatment of cancerAristotle Bamias, Meletios A Dimopoulos
Leukemia & Lymphoma|November 17, 2006
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?Meletios A Dimopoulos, Efstathios Kastritis
Blood|August 23, 2014
Solitary bone plasmacytomas need to flowMeletios A Dimopoulos, Evangelos Terpos
Current Treatment Options in Oncology|June 12, 2002
Solitary bone plasmacytoma and extramedullary plasmacytomaMeletios A Dimopoulos, George Hamilos
Best Practice & Research. Clinical Haematology|November 10, 2016
Current therapy guidelines for Waldenstrom's macroglobulinaemiaEfstathios Kastritis, Meletios A Dimopoulos
Blood|February 1, 2014
Less strength and more fractures for MGUS bonesEvangelos Terpos, Meletios A Dimopoulos
Pageof 74